Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/18048| Title: | De novo activating epidermal growth factor mutations (EGFR) in small-cell lung cancer. | Austin Authors: | Thai, Alesha;Chia, Puey L;Russell, Prudence A;Do, Hongdo;Dobrovic, Alexander ;Mitchell, Paul L R ;John, Thomas | Affiliation: | Department of Medical Oncology, Austin Health, Heidelberg, Victoria, Australia Department of Anatomical Pathology, St Vincent's Hospital, University of Melbourne, Melbourne, Victoria, Australia Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia |
Issue Date: | Sep-2017 | Publication information: | Internal Medicine Journal 2017; 47(9): 1071-1074 | Abstract: | In Australia, mutations in epidermal growth factor mutations (EGFR) occur in 15% of patients diagnosed with non-small-cell lung cancer and are found with higher frequency in female, non-smokers of Asian ethnicity. Activating mutations in the EGFR gene are rarely described in SCLC. We present two cases of de novo EGFR mutations in patients with SCLC detected in tissue and in plasma cell free DNA, both of whom were of Asian ethnicity and never-smokers. These two cases add to the growing body of evidence suggesting that screening for EGFR mutations in SCLC should be considered in patients with specific clinical features. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/18048 | DOI: | 10.1111/imj.13531 | ORCID: | 0000-0001-8966-7677 0000-0003-3414-112X |
Journal: | Internal Medicine Journal | PubMed URL: | 28891180 | Type: | Journal Article | Subjects: | EGFR mutation de novo cell free DNA circulating DNA small-cell lung cancer |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.